PROCEPT BioRobotics Corporation (PRCT) Tops Q3 EPS by 3c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PRCT Hot Sheet
Join SI Premium – FREE
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.38), $0.03 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $83.3 million versus the consensus estimate of $80.83 million.
GUIDANCE:
PROCEPT BioRobotics Corporation sees FY2025 revenue of $325.5 million, versus the consensus of $326.5 million.
PROCEPT BioRobotics Corporation sees FY2026 revenue of $410-430 million, versus the consensus of $427 million.
For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
